Can Acute Stress Activate HIV Reservoirs? New Research Reveals Surprising Connection

Can Acute Stress Influence HIV Reservoirs?

The impact of acute psychological stress on HIV transcription in people living with HIV on antiretroviral therapy has been demonstrated in a groundbreaking controlled clinical trial. This study provides the first prospective evidence that stress can directly influence HIV reservoir activity, with significant implications for HIV cure research and clinical management.

Researchers conducted a controlled interventional trial involving 25 male participants living with HIV who had been on suppressive antiretroviral therapy (ART) for at least three years. The trial employed a within-subject design where each participant underwent both a control visit with no intervention and a subsequent visit featuring the Trier Social Stress Test (TSST), a standardized laboratory procedure designed to induce acute psychological stress through social evaluative threat.

During both visits, blood samples were collected at baseline, 30 minutes, and 65 minutes to measure cell-associated unspliced (CA-US) HIV RNA, HIV DNA, and various immunological parameters. The TSST successfully induced physiological stress responses as evidenced by significant increases in salivary cortisol and changes in autonomic nervous system markers, including decreased pre-ejection period (PEP) and increased cardiac output (CO).

How Does Stress Alter HIV Activity?

The primary finding revealed that acute stress resulted in a 1.57-fold increase in CA-US HIV RNA levels at 65 minutes after stress induction compared to matched timepoints during the control visit. This effect became more pronounced in sensitivity analyses when excluding an outlier participant. Importantly, HIV DNA levels remained stable throughout both visits, indicating that the observed increase in HIV RNA represented enhanced transcription rather than changes in the number of infected cells.

Immunological analyses demonstrated transient shifts in T cell subset distributions during stress, with increases in effector memory and terminally differentiated effector memory cells (TEMRA) for both CD4+ and CD8+ T cells at 30 minutes post-stress. However, these changes normalized by the 65-minute timepoint, suggesting that cell trafficking alone could not explain the sustained increase in HIV transcription. No significant changes were observed in T cell activation markers such as CD38 or HLA-DR expression.

Correlation analyses revealed significant associations between changes in HIV transcription and autonomic nervous system responses. Specifically, greater sympathetic nervous system activation (indicated by decreased PEP) and increased cardiac output strongly correlated with elevated CA-US HIV RNA levels. These findings suggest a direct physiological pathway connecting stress responses to HIV reservoir activity.

The study also conducted in vitro experiments to investigate whether stress-related compounds could directly modulate HIV transcription in latently infected cell lines. Interestingly, none of the tested compounds, including glucocorticoids (hydrocortisone and dexamethasone), catecholamines (epinephrine and norepinephrine), protein kinase A agonist (forskolin), prolactin, or thyroid hormone (Triiodothyronine), increased HIV LTR-mediated expression. In fact, hydrocortisone at any concentration and high-dose dexamethasone actually suppressed LTR-mediated expression in TZM-bl cells but not J-Lat A2 cells, suggesting that the in vivo relationship between stress and HIV transcription likely involves more complex mechanisms beyond direct effects of stress hormones on the HIV promoter.

What Could This Mean for HIV Cure Research?

The study's findings raise important questions about the potential impact of chronic or recurrent stress on the HIV reservoir in people living with HIV. Could persistent psychological stressors contribute to ongoing immune activation and inflammation even in the setting of virologic suppression with ART? This question is particularly relevant given the higher prevalence of stress, depression, and post-traumatic stress disorder among people living with HIV.

The results also have methodological implications for HIV cure research. The observation that stress can influence HIV transcription highlights the need to account for psychological state and timing when designing and interpreting latency reversal studies. Future clinical trials assessing HIV cure interventions should consider standardizing the timing of sample collection and potentially monitoring participants' stress levels to minimize confounding effects.

In participants with a higher change in cortisol during the TSST, there was a significantly greater increase in CA-US HIV RNA, suggesting a potential dose-response relationship between stress intensity and HIV transcription. Additionally, when the researchers divided participants into "high" and "low" cortisol responders, those with high cortisol responses showed a 7.44-fold increase in CA-US HIV RNA compared to low responders, further supporting the biological link between stress physiology and HIV reservoir activity.

The study had several limitations, including its focus exclusively on male participants, the relatively short sampling period, and the measurement primarily of unspliced HIV RNA rather than a more comprehensive assessment of HIV transcription. Additionally, the exclusion of participants with mental health conditions limits the generalizability of findings to the broader population of people living with HIV, many of whom experience psychological comorbidities.

Will Integrating Stress Management Revolutionize HIV Treatment?

This research represents a significant step forward in understanding the complex interplay between psychological factors and HIV persistence. The demonstration that acute stress can induce and sustain increases in HIV transcription highlights the importance of considering psychosocial factors in HIV cure research and potentially in the clinical management of people living with HIV.

How might chronic stress management interventions impact the HIV reservoir and immune function in people living with HIV? Could the development of stress management strategies serve as a complementary approach to traditional HIV cure interventions? What regulatory and implementation challenges might arise when incorporating psychological components into HIV treatment protocols? These questions warrant further investigation, as does the potential role of autonomic nervous system modulation in HIV cure approaches. As research continues to explore the multifaceted barriers to HIV eradication, this study underscores the importance of considering the whole person—including psychological state—in the journey toward an HIV cure.

Summary

A groundbreaking controlled clinical trial has demonstrated that acute psychological stress directly influences HIV reservoir activity in people living with HIV on antiretroviral therapy. The study involved 25 male participants who underwent both a control visit and a stress-inducing session using the Trier Social Stress Test. Results showed that acute stress resulted in a 1.57-fold increase in cell-associated unspliced HIV RNA levels at 65 minutes after stress induction, while HIV DNA levels remained stable, indicating enhanced viral transcription rather than changes in infected cell numbers. The increase in HIV transcription correlated significantly with autonomic nervous system responses, particularly sympathetic activation and increased cardiac output. Participants with higher cortisol responses showed a 7.44-fold increase in HIV RNA compared to low responders, suggesting a dose-response relationship between stress intensity and viral transcription. Interestingly, in vitro experiments revealed that stress-related compounds such as glucocorticoids and catecholamines did not directly increase HIV transcription, indicating that more complex mechanisms are involved in the stress-HIV relationship. These findings have important implications for HIV cure research, suggesting that psychological state and stress levels should be considered when designing clinical trials and potentially when managing people living with HIV. The study raises questions about whether chronic stress management interventions could serve as complementary approaches to traditional HIV cure strategies and highlights the need to consider psychosocial factors in the journey toward HIV eradication.